After a year of turmoil, cancer researchers see promising signs for mRNA vaccines [CNN]
Revolution Medicines, Inc. (RVMD)
Company Research
Source: CNN
“It's exciting,” said Elizabeth Jaffee, deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University. “There's been a number of successes in early-stage, positive trials.” Dr. Catherine Wu, a professor of medicine at Dana Farber Cancer Institute and Harvard Medical School, says the recent stretch of positive real-world results helped drive the recent announcement by the National Cancer Institute that it would help raise $200 million specifically for novel cancer vaccines. “We're getting a lot of support from NCI in terms of developing and promoting cancer vaccines, and mRNA vaccines are a major part of that portfolio,” she said. An unforgiving enemy To guide her treatment, Blechner turned to doctors at Memorial Sloan Kettering Cancer Center, including Dr. Vinod Balachandran, director of MSK's Olayan Center for Cancer Vaccines. It's more challenging to make a vaccine against cancer than it is to create a vaccine against a virus or bacteria, Ba
Show less
Read more
Impact Snapshot
Event Time:
RVMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVMD alerts
High impacting Revolution Medicines, Inc. news events
Weekly update
A roundup of the hottest topics
RVMD
News
- AACR 2026: Revolution's next prospect, Merck's reveal and a lung cancer battle [Yahoo! Finance]Yahoo! Finance
- Revolution Medicines (RVMD) had its "buy" rating reaffirmed by Stifel Nicolaus. They now have a $215.00 price target on the stock, up from $170.00.MarketBeat
- After a year of turmoil, cancer researchers see promising signs for mRNA vaccines [CNN]CNN
- Revolution Medicines (RVMD) Jumps 54% on Stellar Drug Trial Results [Yahoo! Finance]Yahoo! Finance
- Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting [Yahoo! Finance]Yahoo! Finance
RVMD
Earnings
- 2/25/26 - Miss
RVMD
Sec Filings
- 4/17/26 - Form 4
- 4/17/26 - Form 8-K
- 4/16/26 - Form 8-K
- RVMD's page on the SEC website